Wolverine Trading, LLC Corcept Therapeutics Inc Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$29.51 - $46.26 $929,565 - $1.46 Million	31,500 New	31,500 $1.46 Million
Q3 2023 Nov 15, 2023	BUY	$21.97 - $33.8 $432,809 - $665,860	19,700 New	19,700 $536,000
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $946,560 - $1.21 Million	49,300 New	49,300 $1.07 Million
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $202,540 - $238,784	8,200 New	8,200 $209,000
Q3 2021 Nov 12, 2021	SELL	$19.68 - $22.53 $517,584 - $592,539	-26,300 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$19.97 - $24.43 $525,211 - $642,509	26,300 New	26,300 $585,000
Q4 2020 Feb 12, 2021	SELL	$16.78 - $27.3 $325,532 - $529,620	-19,400 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$12.46 - $19.98 $16,198 - $25,974	-1,300 Reduced 6.28%	19,400 $340,000
Q2 2020 Aug 13, 2020	SELL	$11.0 - $18.26 $90,200 - $149,732	-8,200 Reduced 28.37%	20,700 $347,000
Q1 2020 May 11, 2020	SELL	$10.11 - $14.04 $392,268 - $544,752	-38,800 Reduced 57.31%	28,900 $338,000
Q4 2019 Feb 12, 2020	BUY	$12.06 - $16.96 $481,194 - $676,704	39,900 Added 143.53%	67,700 $816,000
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $30,189 - $42,514	2,900 Added 11.65%	27,800 $405,000
Q2 2019 Aug 20, 2019	SELL	$9.78 - $12.76 $232,763 - $303,688	-23,800 Reduced 48.87%	24,900 $278,000
Q1 2019 May 15, 2019	BUY	$10.03 - $15.71 $150,450 - $235,650	15,000 Added 44.51%	48,700 $572,000
Q4 2018 Feb 14, 2019	SELL	$11.29 - $17.19 $4,516 - $6,876	-400 Reduced 1.17%	33,700 $439,000
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $418,407 - $533,665	34,100 New	34,100 $478,000
Q1 2018 May 15, 2018	SELL	$14.59 - $25.5 $964,399 - $1.69 Million	-66,100 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$15.77 - $20.72 $15,770 - $20,720	-1,000 Reduced 1.49%	66,100 $1.19 Million
Q3 2017 Nov 15, 2017	BUY	$12.3 - $19.3 $825,330 - $1.3 Million	67,100	67,100 $1.3 Million

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

Black Rock Inc. New York, NY

16.5M
Shares

$842 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$509 Million
0.01% of portfolio
Ingalls & Snyder LLC New York, NY

8.27M
Shares

$421 Million
14.93% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

6.51M
Shares

$331 Million
0.48% of portfolio
Parallel Advisors, LLC

3.81M
Shares

$194 Million
4.22% of portfolio

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.45B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account